About Aimil Pharmaceuticals(India) Limited
Data last updated:
Aimil Pharmaceuticals(India) Limited is a public limited company based in New, Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 30 November 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1984PLC019461. Its GSTIN is 07AAACA6166G1ZT (Delhi). The company holds 24 GST registrations, of which 20 are active.
The company has an authorised share capital of ₹14.5 Cr and a paid-up capital of ₹11.55 Cr. It was formerly known as Aimil Pharmaceuticals India Private Limited. It is led by directors including Kanwal Kumar Sharma (Managing Director) and Ikshit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 2994/4 Street No 17 Ranjeet Nagar, New, Delhi, India – 110008.
As per the financials filed for FY 2023, the company reported a revenue of ₹480.65 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.01 Cr (net margin 1%) and EBITDA of ₹25.92 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 11% over five years.
The company has about 195 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aimil Pharmaceuticals. As per MCA filings, the company has open charges of ₹94.34 Cr and satisfied charges of ₹24 Cr on record. Court records list 102 cases involving the company, including 51 filed by the company and 48 filed against it; 19 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aimilpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address2994/4 Street No 17 Ranjeet Nagar, New, Delhi, India – 110008
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aimil Pharmaceuticals(India) Limited
The main business activity of Aimil Pharmaceuticals(India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aimil Pharmaceuticals(India) Limited FY 2023 filings available
Aimil Pharmaceuticals(India) Limited reported revenue of ₹480.65 Cr (up 7% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Aimil Pharmaceuticals(India) Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aimil Pharmaceuticals(India) Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹480.65 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25.92 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.01 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aimil Pharmaceuticals(India) Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aimil Pharmaceuticals(India) are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Siddhayu Ayurvedic Research Foundation Pvt Ltd | •••• | •••• | •••• | •••• | 396 | Mumbai, Maharashtra, India |
| Maxcure Nutravedics Limited | •••• | •••• | •••• | •••• | 199 | Delhi, India |
| Mountain Valley Springs India Private Limited | •••• | •••• | •••• | •••• | 1,494 | New Delhi, Delhi, India |
| Natural Remedies Private Limited | •••• | •••• | •••• | •••• | 669 | Bangalore, Karnataka, India |
| Patanjali Agro India Private Limited | •••• | •••• | •••• | •••• | 34 | Haridwar, Uttarakhand, India |
| Aimil Pharmaceuticals(India) Limited this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Jeena Sikho Lifecare Limited | •••• | •••• | •••• | •••• | 2,283 | Zirakpur, Punjab, India |
| Amrutanjan Health Care Limited Listed | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Amrita Enterprises Private Limited | •••• | •••• | •••• | •••• | - | Puducherry, Pondicherry, India |
| SBL Private Limited | •••• | •••• | •••• | •••• | 1,012 | Haridwar, Uttarakhand, India |
| Arjuna Natural Private Limited | •••• | •••• | •••• | •••• | 439 | Aluva, Kerala, India |
Peers are the five companies nearest above and the five nearest below Aimil Pharmaceuticals(India) by revenue in the Healthcare industry (Ayurvedic Products and Services), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) Limited is audited by Ambani & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ambani & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ikshit Sharma | Director | 21 Nov 2019 | 6 Years 10 Months | Current |
| Sanchit Sharma | Additional Director | 12 Feb 2025 | 1 Years 7 Months | Current |
| Kanwal Kumar Sharma | Managing Director | 30 Nov 1984 | 41 Years 10 Months | Current |
| Pankaj Marwaha | Director | 26 Sep 1988 | 38 Years 0 Months | Current |
| Satya Prakash Shrivastava | Director | 18 Aug 2014 | 12 Years 1 Months | Current |
| Manjula Sharma Also directs: Aimil India Research Foundation | Director | 24 Jul 1996 | 30 Years 2 Months | Current |
Ownership and Shareholding of Aimil Pharmaceuticals(India) Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aimil Pharmaceuticals(India) Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2023 | Tata Capital Financial Services Limited | ₹1.75 Cr | Open |
| 29 Oct 2021 | Others | ₹13.75 Cr | Open |
| 08 Oct 2021 | Others | ₹34.75 Lakh | Open |
| 14 Oct 2019 | Others | ₹83.51 Lakh | Open |
| 04 Jan 2017 | Others | ₹15.9 Lakh | Open |
Total charge records: 21 View all charges
Legal Cases of Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) Limited has 102 court cases on record: 51 filed by Aimil Pharmaceuticals(India), 48 filed against it, 3 where it is another party. 19 cases are pending and 83 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 79 | 35 | 17 |
| High courts | 23 | 13 | 2 |
Cases on record (5 of 102)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Konark Herbals and Healthcare Private Limited | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Ocl Shipping (India) Private Limited | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by Maxcomm India Private Limited | Disposed |
| District court, West, Delhi | Commercial suit | Filed by the company against Sanjay Baljiwan Ayurvedic Pharmacy Private Limited | Disposed |
| District court, West, Delhi | Commercial suit | Filed by the company against Kayos Logistics India Private Limited | Disposed |
Full case history
All 102 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) operates one associated brand: Aimil Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Ayurvedic pharmaceutical products and natural healthcare solutions in India. | aimilpharmaceuticals.com |
Employees and EPFO Compliance at Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) Limited has a workforce of 195 employees as of Jan 09, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Aimil Pharmaceuticals(India) Limited
Recent Activity on Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) Limited has 10 board changes on record since 1984: 6 appointments and 4 cessations. The latest: Sanchit Sharma was appointed as Additional Director on 12 Feb 2025.
39 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Aimil Pharmaceuticals(India) Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aimil Pharmaceuticals(India) Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aimil Pharmaceuticals(India) Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) has 24 GST registrations: 20 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACA6166G1ZT | Delhi | Active | 01 Jul 2017 |
| 02AAACA6166G1Z3 | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACA6166G1Z1 | Punjab | Active | 01 Jul 2017 |
| 06AAACA6166G1ZV | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aimil Pharmaceuticals(India) Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) is an active public limited company based in New, Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 30 November 1984 (42+ years old) and is registered under CIN U24231DL1984PLC019461.
Aimil Pharmaceuticals(India) reported revenue of ₹480.65 Cr for FY 2023 (up 7% YoY).
Aimil Pharmaceuticals(India) has 6 current directors:
- Kanwal Kumar Sharma - Managing Director
- Ikshit Sharma - Director
- Sanchit Sharma - Additional Director
- Pankaj Marwaha - Director
- Satya Prakash Shrivastava - Director
- Manjula Sharma - Director
Aimil Pharmaceuticals(India) reported a net profit of ₹5.01 Cr (net margin 1%) and EBITDA of ₹25.92 Cr (EBITDA margin 5.4%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aimil Pharmaceuticals(India) is 18% over three years and 11% over five years. In the latest year (FY 2023) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aimil Pharmaceuticals(India) is 07AAACA6166G1ZT, registered in Delhi. The company has 24 GST registrations in all, of which 20 are active and 4 are cancelled or inactive. Other active GSTINs include 02AAACA6166G1Z3 (Himachal Pradesh), 03AAACA6166G1Z1 (Punjab), 06AAACA6166G1ZV (Haryana).
The CIN (Corporate Identification Number) of Aimil Pharmaceuticals(India) is U24231DL1984PLC019461. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aimil Pharmaceuticals(India) has 102 court cases on record: 51 filed by the company and 48 filed against it. 19 are pending. Most are in the district courts.
Aimil Pharmaceuticals(India) was incorporated on 30 November 1984, making it 42+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aimil Pharmaceuticals(India) by revenue are Siddhayu Ayurvedic Research Foundation Pvt Ltd, Maxcure Nutravedics Limited, Mountain Valley Springs India Private Limited, Natural Remedies Private Limited, Patanjali Agro India Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services).
Sanchit Sharma was appointed as Additional Director on 12 Feb 2025. Ikshit Sharma ceased to be Additional Director on 31 Dec 2020. Ikshit Sharma was appointed as Director on 21 Nov 2019. Aimil Pharmaceuticals(India) has 10 board changes on record in total.